AIPT Insider Trading Activity and SEC Form 4 Filings
AIPT insider trading summary
No open-market insider purchases or sales of Precision Therapeutics Inc. (AIPT) have been reported on SEC Form 4 in the past 12 months.
Latest AIPT insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| May 24, 2019 | Carl I. Schwartz | Chief Executive Officer | Buy | $27K (48,332 @ $0.55) |
| May 23, 2019 | Carl I. Schwartz | Chief Executive Officer | Buy | $29K (51,668 @ $0.56) |
| Jan 8, 2019 | Carl I. Schwartz | Chief Executive Officer | Buy | $50K (78,125 @ $0.64) |
| Dec 11, 2018 | Richard L Gabriel | Director | Buy | $1K (2,000 @ $0.68) |
| Nov 28, 2018 | Richard L Gabriel | Director | Buy | $2K (2,000 @ $0.78) |
| Nov 20, 2018 | Richard L Gabriel | Director | Buy | $890 (1,000 @ $0.89) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.